20 (AIDX) Current Assets (2024 - 2026)

20's (AIDX) quarterly Current Assets came in at $4.7 million in Q1 2026, up 219.5% on a QoQ basis from $1.5 million in Q4 2025.

20 (AIDX) Current Assets (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Current Assets data on file, last reported at $4.7 million in Q1 2026.

Quarterly Current Assets changed N/A year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (changed N/A YoY) and the FY2025 annual result came in at $1.5 million, down 27.68% from the prior year.
Current Assets advanced to $4.7 million in Q1 2026, from $1.5 million in the prior quarter.
In the past five years, Current Assets ranged from a high of $4.7 million in Q1 2026 to a low of $1.5 million in Q4 2025.
A 3-year average of $2.7 million and a median of $2.0 million in 2024 frame the typical range for Current Assets.
The widest YoY moves for Current Assets: up 27.68% in 2025, down 27.68% in 2025.
Tracing AIDX's Current Assets over 3 years: stood at $2.0 million in 2024, then retreated by 27.68% to $1.5 million in 2025, then soared by 219.5% to $4.7 million in 2026.
The last three Current Assets figures came in at $4.7 million (Q1 2026), $1.5 million (Q4 2025), and $2.0 million (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Assets (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	24.52 Bn
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	14.42 Bn
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	24.79 Bn
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	7.97 Bn
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	6.82 Bn
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	4.09 Bn
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	10.50 Bn
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	10.84 Bn
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	2.45 Bn
10	20	5.45 Mn	905,333.06	304,727.00	5.08 Mn

Download Data